Financials Medipower (Overseas) Public Co. Limited
Equities
MDPR
CY0100361019
Real Estate Development & Operations
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
472.8 ILa | +0.60% | -1.44% | -17.07% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 41.71 | 73.21 | 74.31 | 92.73 | 83.66 | 80.71 |
Enterprise Value (EV) 1 | 142.7 | 177.9 | 234.5 | 347.2 | 345.5 | 331.9 |
P/E ratio | 9.1 x | 17.7 x | 29.4 x | 9.49 x | 61.8 x | 10.1 x |
Yield | 3.44% | - | - | - | - | - |
Capitalization / Revenue | 2.15 x | 3.83 x | 3.1 x | 3.01 x | 2.23 x | 2.09 x |
EV / Revenue | 7.36 x | 9.31 x | 9.78 x | 11.3 x | 9.2 x | 8.59 x |
EV / EBITDA | 12.6 x | - | - | - | - | - |
EV / FCF | 22.6 x | 48.7 x | 47.9 x | -46.2 x | 40.9 x | 20.6 x |
FCF Yield | 4.42% | 2.05% | 2.09% | -2.16% | 2.44% | 4.86% |
Price to Book | 0.6 x | 1.01 x | 0.99 x | 1.11 x | 0.73 x | 0.65 x |
Nbr of stocks (in thousands) | 38,266 | 38,266 | 38,266 | 44,637 | 51,137 | 51,137 |
Reference price 2 | 1.090 | 1.913 | 1.942 | 2.077 | 1.636 | 1.578 |
Announcement Date | 3/20/19 | 3/19/20 | 3/14/21 | 3/24/22 | 3/26/23 | 3/21/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 19.39 | 19.11 | 23.98 | 30.8 | 37.54 | 38.62 |
EBITDA 1 | 11.35 | - | - | - | - | - |
EBIT 1 | 11.34 | 11.22 | 15.01 | 19.25 | 22.62 | 23.57 |
Operating Margin | 58.49% | 58.69% | 62.6% | 62.5% | 60.27% | 61.03% |
Earnings before Tax (EBT) 1 | 4.936 | 5.337 | 4.461 | 16.67 | 6.446 | 10.28 |
Net income 1 | 4.584 | 4.127 | 2.531 | 9.189 | 1.345 | 8.004 |
Net margin | 23.64% | 21.59% | 10.56% | 29.83% | 3.58% | 20.72% |
EPS 2 | 0.1198 | 0.1078 | 0.0660 | 0.2189 | 0.0265 | 0.1565 |
Free Cash Flow 1 | 6.311 | 3.651 | 4.9 | -7.509 | 8.439 | 16.13 |
FCF margin | 32.54% | 19.1% | 20.44% | -24.38% | 22.48% | 41.77% |
FCF Conversion (EBITDA) | 55.62% | - | - | - | - | - |
FCF Conversion (Net income) | 137.68% | 88.47% | 193.59% | - | 627.44% | 201.54% |
Dividend per Share 2 | 0.0375 | - | - | - | - | - |
Announcement Date | 3/20/19 | 3/19/20 | 3/14/21 | 3/24/22 | 3/26/23 | 3/21/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 101 | 105 | 160 | 254 | 262 | 251 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 8.899 x | - | - | - | - | - |
Free Cash Flow 1 | 6.31 | 3.65 | 4.9 | -7.51 | 8.44 | 16.1 |
ROE (net income / shareholders' equity) | 6.34% | 5.51% | 3.52% | 13% | 3.68% | 6.01% |
ROA (Net income/ Total Assets) | 3.63% | 3.41% | 3.88% | 3.6% | 3.43% | 3.52% |
Assets 1 | 126.3 | 120.9 | 65.27 | 255.2 | 39.18 | 227.5 |
Book Value Per Share 2 | 1.820 | 1.900 | 1.970 | 1.870 | 2.230 | 2.420 |
Cash Flow per Share 2 | 0.1800 | 0.6700 | 0.3300 | 0.0800 | 0.1400 | 0.1000 |
Capex | - | - | - | - | 0.08 | - |
Capex / Sales | - | - | - | - | 0.22% | - |
Announcement Date | 3/20/19 | 3/19/20 | 3/14/21 | 3/24/22 | 3/26/23 | 3/21/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-17.07% | 65.48M | |
+6.35% | 11.13B | |
+67.14% | 8.03B | |
+12.48% | 3.29B | |
+6.74% | 2.68B | |
-6.36% | 2.6B | |
-14.95% | 2.56B | |
-3.46% | 2.54B | |
-16.38% | 2.21B | |
+20.11% | 2.15B |
- Stock Market
- Equities
- MDPR Stock
- Financials Medipower (Overseas) Public Co. Limited